当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Anti-virus {virus COVID-19}: Yes! Were used to Resolve it as a Cancer Problem. It Works for Ebola

Winston Vo

When viruses infect host cells or organs, the dysfunction of these parts (or tumors) is a result. We name it “a tumor” then we tackle it as a cancer issue! Very straightforward: it works for Ebola.

We have options in oncology: Surgery, Radiation, Chemotherapy, and Immunotherapy. Depending on the rate of its spread, we use one or a combination of those treatments. The rate of success depends on the stage (spread of tumors).

Infection with COVID-19 often causes a severe acute respiratory syndrome. We could consider it as a lung cancer, and treatment plans for it are already well-established in the field of oncology. It’s a virus, so the patient should be considered a candidate for treatment with immunotherapy (or vaccines) based on our body’s defense against cancer.